Drug maker Tesaro Inc. is exploring a sale, The Wall Street Journal reported Wednesday, citing people familiar with the matter. The company, which two months ago won a key approval for its ovarian cancer drug, has asked for offers in recent weeks, but interest has been tepid and no deal might be forthcoming, according to the report. Tesaro shares rallied on the news and closed 4% higher.
Continue Reading Below
Copyright © 2017 MarketWatch, Inc.